# Steroids-Based Screening for Primary Aldosteronism

> **NCT06941116** · — · RECRUITING · sponsor: **Qifu Li** · enrollment: 406 (estimated)

## Conditions studied

- Primary Aldosteronism
- Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** Steroid-Based Screening (LC-MS/MS)

## Key facts

- **NCT ID:** NCT06941116
- **Lead sponsor:** Qifu Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-15
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 406 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06941116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06941116, "Steroids-Based Screening for Primary Aldosteronism". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06941116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*